Introduction
Infection is a potentially life-threatening complication of cardiac device implantation.
In previous reports, the rate of infection varies from 0.13-19.9%. 1, 2, 3, 4 The severity of infection ranges from localized infection in the device pocket to systemic infection associated with bacteremia and endocarditis. Lead associated-endocarditis (LAE) is the most serious complication related to cardiac device implantation with mortality ranging from 10-21%. 2, 5, 6, 7, 8, 9, 10 Previous reports have emphasized skin flora as the likely source for LAE. Coagulase-negative staphylococci are reported as the most likely organisms followed by Staphylococcus aureus. These reports are from an earlier period, before the importance of antibiotic-resistant organisms such as methicillin-resistant Staphylococcus aureus (MRSA) was emphasized. We hypothesized that MRSA may account for a greater percentage of device-related infections than previously reported. Therefore, we retrospectively reviewed cases of LAE referred to our institution to evaluate the clinical presentation, microbiology, and course of these patients.
Methods
We performed a retrospective review of the medical records of patients with leadassociated endocarditis referred to Thomas Jefferson University Hospital between 1999
and 2007. The study proposal was approved by the Institutional Review Board.
Definitions
A diagnosis of infective endocarditis was based on the modified Duke criteria. 11 Specifically, lead-associated endocarditis was defined as persistent bacteremia in the presence of a vegetation documented by echocardiography, a vegetation without 6 bacteremia in a patient treated with antibiotics, or persistent unexplained bacteremia without any another identifiable source. In patients with fever and persistent unexplained bacteremia, a diagnosis of LAE was presumed since bacteremia and fever resolved promptly upon removal of the device and leads despite the absence of a vegetation on imaging. A vegetation was defined as an oscillating intracardiac mass on the electrode leads or cardiac leaflets which was present in more than one echocardiographic plane.
For the purposes of this analysis, early LAE was defined as infection occurring within six months of implantation or device replacement. If infection occurred more than six months following surgery, it was defined as late LAE.
Diagnosis and Treatment
Multiple blood cultures were obtained in each patient. A transthoracic echocardiogram was initially performed in all patients. If a vegetation was not present by transthoracic echocardiogram, a trans-esophageal echocardiogram was performed.
All patients underwent removal and extraction of all hardware. Prior to extraction, all patients had a temporary transvenous pacemaker placed via a femoral vein. A bacterial culture was performed on the pulse generator site. Following the procedure, intravenous antibiotics, based on the results of culture and sensitivity, were administered for a total of six weeks. If bacterial cultures were unrevealing, empiric antimicrobials were prescribed intravenously for six weeks. A new device was implanted on the contralateral side (if clinically indicated), once the patient had received at least 14 days of appropriate intravenous antibiotics. Relapse was defined as a recurrence of infection with the same organism.
Results

Baseline Characteristics
A total of 107 patients with device-related infections were referred to our center during the study period. Of these, 51 cases met the criteria for LAE and are included in this report. (Table I) The mean age of the patients was 68±11 years (range 42 to 83 years). Seventy-seven percent were male. Devices included permanent pacemakers in 33 (65%) and ICDs in 18 (35%). LAE occurred following the initial implantation in 33 (65%), after a revision or upgrade in 8 (15%), and following a pulse generator replacement in the remaining 10 (20%). Sixteen patients (31%) had diabetes mellitus, 7 (14%) had chronic renal insufficiency (defined as a serum creatinine greater than 3 mg/dl) with 6 of these patients requiring chronic hemodialysis, and 2 were on chronic oral steroids.
The most common presenting symptom was fever (51%). Eleven patients (22%) presented with symptoms resulting from infection at a remote site, while pain at the generator site was the predominant complaint in three patients (6%). The remaining eight patients presented with nonspecific complaints such as malaise. LAE was diagnosed by the finding of bacteremia and vegetation in 33, vegetation without bacteremia on antibiotics in 1, and persistent bacteremia without any identifiable source in 17.
The timing of the LAE was divided into two groups based on the timing of the most recent device procedure. (Figure 1 patients. Vegetations were measured up to 3.5 cm. Vegetations greater than 2 cm in diameter were seen in six patients.
Bacteriology
Blood cultures were positive in 47/51 patients upon presentation to our institution;
18/19 patients with early LAE and 29/32 patients with late LAE had positive blood cultures. All patients with negative blood cultures had been previously treated with intravenous antibiotics prior to hospital admission or transfer. Overall, 17/51 patients had positive pocket or wound cultures. Seven of 19 (37%) early LAE and 10/32 (31%) late LAE patients had positive pocket cultures. In all cases, the organism responsible for the positive pocket culture was identical to the one obtained from the blood culture.
In the total group of 51 patients, Staphylococcus aureus was the most common cause of LAE (53%), followed by coagulase-negative staphylococci (22%) and streptococci (12%). Methicillin resistance was present in 67% of the patients infected with
Staphylococcus aureus. There were differences in bacteriology between early and late cases of LAE. (Figure 2 ) Though Staphylococcus aureus was the predominant organism in both early and late cases, more early LAE cases had methicillin-resistant organisms (83% vs 50%). Coagulase-negative staphylococci were responsible for only 26% of early cases and 19% of late cases.
A distant site of infection was present in approximately one half of the patients (26/51). (Table II This patient had chronic osteomyelitis which may have been the remote source of both infections. The surviving patients were followed for at least six months post procedure and had no evidence of recurrent infection.
Discussion
The rate of implantation of cardiac rhythm management devices continues to grow. years. 13 This may relate to the fact that device-related infection is higher for ICDs than pacemakers.
14 Lead associated endocarditis is present in only 10% of device-related infections but is associated with high mortality, morbidity and economic cost. 3 Prompt recognition and management is imperative as 6% of our patients died during the index hospitalization despite uncomplicated extraction of their hardware and administration of appropriate intravenous antibiotics. Previous reports have highlighted the importance of skin flora, such as coagulase-negative staphylococci as pathogenic organisms in these device infections. However, while LAE more commonly occurs early post implantation, it may occur at any time following implantation or replacement. The present report highlights the changing bacteriology of LAE and the potential importance of LAE stemming from distant sites of infection particularly with organisms such as MRSA.
Bacteriology
The most common pathogens associated with LAE are skin flora. By contrast, we found that Staphylococcus aureus was the most common pathogen responsible for both early and late infections. We chose to divide LAE infections into early and late based on a six month window following the most recent procedure, since infection by Staphylococcus aureus arising from contamination of the operative site would most likely occur within that time frame. However, we realize that this cut-off is somewhat arbitrary and does not exclude the possibility that LAE after 6 months could arise from the operative site. In our population, Staphylococcus aureus accounted for 58% of early and 50% of late LAE. Importantly, MRSA was responsible for 53% of all 13 early LAE and 25% of late LAE. This highlights the emerging role of this organism in LAE.
Relationship between S.aureus bacteremia and LAE
Most patients who presented with MRSA infection and LAE demonstrated an additional remote site of infection. It is unclear whether these distant sites of infection represent the source of LAE or instead represent secondary seeding as a result of the LAE. Our data do suggest, however, that hematogenous spread of organisms, rather than local invasion from an infected operative site, is the more likely mechanism for LAE.
Previous investigators have emphasized the high risk of device infection in patients who
develop Staphylococcus aureus bacteremia. 15 Chamis and co-workers found that cardiac device infection occurred in approximately 70% of patients with Staphylococcus aureus bacteremia and an implanted cardiac device. Hematogenous spread of the organism was responsible for the infection in 27.3% of cases. Likewise, Camus and colleagues reported that sustained Staphylococcus aureus or coagulase-negative staphylocooci bacteremia was associated with device infection in 67% of their patients. 16 We found that 67% of our patients had no detectable signs of pulse generator pocket infection. This is in agreement with previous reports 15, 16 which suggest that hematogenous spread of Staphylococcus aureus is an important cause of LAE.
Emergence of antibiotic resistant organisms
Methicillin-resistant staphylococcus aureus has emerged as an important pathogen in both hospital acquired and community acquired infections. 17, 18, 19 These infections are associated with both a high mortality and morbidity despite improvements in recognition and antibiotic treatment. The rise in the incidence of Staphylococcus aureus infections parallels the increase in the use of intravascular devices and implantable devices. 17 Although many of our patients were hospitalized for the treatment of noncardiac issues and developed infected intravenous or dialysis catheters or wound infections, a number developed MRSA in non-hospital settings (e.g. following IV drug abuse, paraspinal abscess following epidural analgesia, and osteomyelitis).
14
The reason for the increase in Staphylococcus aureus infections in patients with cardiac devices is not clear. One factor may relate to the increase in ICDs as a percentage of cardiac device implants. 12 As compared to patients with permanent pacemakers, ICD patients generally have more co-morbidities such as heart failure and renal failure. Such comorbidities, make them more likely to be hospitalized or have invasive procedures which may expose them to organisms such as staphylococcus aureus.
Treatment and outcome
Prompt recognition of LAE, treatment with intravenous antibiotics, and removal of all device hardware is important to a successful outcome. 2, 3, 5, 7, 8, 9, 10 It has been suggested that intravenous vancomycin be administered initially until a specific pathogen has been identified since it is generally effective against MRSA. 20 vegetations may be at particular risk for pulmonary emboli. In these patients, thoracotomy and removal under direct vision should be considered. 2, 3 However, in patients who are critically ill and at high risk for thoracotomy and general anesthesia, percutaneous extraction remains an appropriate option. Of interest is the fact that 6 of our patients had vegetations measuring greater than 2 cm in diameter. All had their leads safely extracted without clinical pulmonary emboli, including the patient with a 3.5 cm vegetation.
Limitations
The results of this investigation may be influenced by referral bias since we are a tertiary care center for lead extraction. Our population was quite ill with many comorbidities and had a high incidence of Staphylococcus aureus bacteremia and LAE. In addition, LAE represented approximately one-half of those patients referred for treatment of device related infections. It is likely that many more patients with localized infection
were cared for at their local institution. Therefore, other centers may not have the same experience. Nonetheless, the marked increase in staphylococcus aureus as the cause for LAE along with the high incidence of MRSA suggests that the bacteriology of LAE may be changing.
The diagnosis of LAE may be difficult to establish, particularly in patients with persistent, unexplained bacteremia on antibiotics who have no vegetation detectable by echocardiography. We are confident that our 17 patients with persistent unexplained bacteremia had LAE since their fever and bacteremia promptly resolved upon removal of the implantable device and leads. The possibility that rapid clinical improvement had nothing to due with device and lead removal cannot be completely excluded.
Conclusions
Infection, particularly lead-associated endocarditis, is a serious, life-threatening complication of cardiac device implantation. Prompt recognition and management is essential for improving outcome. Our data suggests that methicillin-resistant 
